- Email: [email protected]
Does Complete Pathologic Response to Neoadjuvant Radiotherapy Predict Oncologic Outcome in Patients With Soft Tissue Sarcoma?
194
ASSOCIATION FOR ACADEMIC SURGERY AND SOCIETY OF UNIVERSITY SURGEONS—ABSTRACTS
7.2. The Prognostic Significance of Lymph Node Ratio in Melanoma. M. E. Egger,1 C. R. Scoggins,1 R. C. Martin,1 A. J. Stromberg,2 A. R. Quillo,1 K. M. McMasters,1 G. G. Callender1; 1 University of Louisville, Louisville, KY; 2University of Kentucky, Lexington, KY 7.3. Merkel Cell Carcinoma: High Recurrence Rate Despite Aggressive Treatment. M. C. Soult,1 E. C. Feliberti,1 M. L. Silverberg,2 R. R. Perry1; 1Eastern Virginia Medical School Department of Surgery, Norfolk, VA; 2Sentara Norfolk Gernal Hospital Department of Pathology, Norfolk, VA 7.4. Expression Profiles of Metalloproteinases in Cutaneous Squamous Cell Carcinoma. A. P. Tufaro,1 N. Prasad,1 A. Chuang,3 J. Wright,4 N. Liegeois,5 A. C. Fischer6; 1Johns Hopkins University School of Medicine, Baltimore, MD; 2Johns Hopkins University School of Medicine, Baltimore, MD; 3 University of Chicago Pritzker School of Medicine, Chicago, IL; 4Johns Hopkins University School of Medicine, Baltimore, MD; 5University of Maryland Medical Center, Baltimore, Maryland; 6UT Southwestern Medical Center, Dallas, TX 7.5. Oral Cavity Squamous Carcinoma; Effects of Primary Site on Survival. M. S. Wachtel, T. Nguyen, J. Cordero; Texas Tech University Health Sciences Center, Lubbock, TX 7.6. Molecular Mechanism of SFRP2 in Angiosarcoma and Development of SFRP2 Targeted Therapeutic. E. M. Fontenot,1 X. J. Shen,1 P. Ma,2 R. J. Mumper,2 S. SiamakpourReihani,1 B. Bone,1 E. G. Hilliard,1 D. P. Ketelsen,1 C. M. Ross,1 C. Patterson,1 N. Klauber-Demore1; 1UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; 2Department of Pharmacology, Chapel Hill, NC
University of Iowa Carver College of Medicine, Department of Surgery, Iowa City, IA 7.12. One-step Nucleic Acid Amplification (OSNA) Assay for Lymph Node Metastases in Lung Cancer Patients. M. Hayama,1 M. Chida,1 M. Nishihira,1 Y. Karube,1 M. Tamura,1 S. Kobayashi,1 T. Oyaizu,1 K. Honma2; 1Department of General Thoracic Surgery, Dokkyo Medical University, Shimotsuga, Tochigi; 2Department of Pathology, Dokkyo Medical University, Shimotsuga, Tochigi
7.13. Radioguided Detection of Lymph Node Metastasis in Non-Small Cell Lung Cancer. C. E. Nwogu,1,2 M. E. Reid,1 E. U. Dexter,1,2 P. N. Bogner,1 S. S. Yendamuri,1,2 C. D. Morrison,1 R. T. Cheney,1 D. Lamonica,1 A. Hutson,1,2 T. L. Demmy,1,2 A. A. Adjei1; 1Roswell Park Cancer Institute, Buffalo, NY; 2State University of New York at Buffalo, Buffalo, NY
7.14. Pre-Operative Core Muscle Cross-Sectional Area is Associated With Long-Term Survival Following Tri-Modality Management of Esophageal Carcinoma. K. H. Sheetz,1 L. Zhao,1 S. A. Holcombe,1 J. A. Hayman,3 S. G. Urba,2 R. M. Reddy,1 J. Lin,1 M. B. Orringer,1 S. C. Wang,1 A. C. Chang1; 1 University of Michigan Medical School, Department of Surgery, Ann Arbor, MI; 2University of Michigan Medical School, Division of Hematology/Oncology, Ann Arbor, MI; 3 University of Michigan Medical School, Department of Radiation Oncology, Ann Arbor, MI
7.15. Withdrawn 7.7. Fertility Preservation in Young Cancer Patients: Transplantation of Isolated Ovarian Follicles in Biomaterials in a Mouse Model of Infertility. A. N. Hardy,1 S. A. Boukaidi,5 L. D. Shea,2,3,4 J. S. Jeruss1,2; 1Department of Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL; 2The Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; 3Department of Chemical and Biological Engineering, Northwestern University, Evanston, IL; 4Institute for BioNanotechnology in Advanced Medicine, Northwestern University, Chicago, IL; 5Department of Gynecology and Obstetrics, University of Nice Sophia Antipolis, Nice, Provence Alpes Cote D’Azur 7.8. Imatinib-Resistant GIST Metastases: Predicting Outcomes of Surgical Resection. K. T. Chen, J. Farma, M. Von Mehren, J. C. Watson; Fox Chase Cancer Center, Philadelphia, PA 7.9. Does Complete Pathologic Response to Neoadjuvant Radiotherapy Predict Oncologic Outcome in Patients With Soft Tissue Sarcoma? D. R. Shah, D. Borys, S. R. Martinez, C. Li, R. J. Tamurian, R. J. Bold, R. J. Canter; University of California - Davis, Sacramento, CA 7.10. Importance of Connective Tissue Growth Factor in Sox2-Induced Oncogenesis. J. M. Hanna, M. Onaitis; Duke University Medical Center, Durham, NC 7.11. Mutations in SMAD4 Lead to Increased Invasive Potential. J. C. Carr, F. S. Dahdaleh, D. Wang, J. R. Howe;
7.16. Validation of Quantitative Histopathology in Identifying Aggressive Cutaneous Squamous Cell Carcinoma. E. S. Glazer,1 P. H. Bartels,1,3 A. R. Prasad,1,2,3 M. L. Yozwiak,3 H. G. Bartels,3 J. G. Einspahr,3 D. S. Alberts,1,3 R. S. Krouse1,2,3; 1The University of Arizona, Tucson, AZ; 2 Southern Arizona VA Health Care System, Tucson, AZ; 3The Arizona Cancer Center, Tucson, AZ
7.17. Regulatory T-cell Subpopulations in Patients With Pulmonary Adenocarcinoma. J. D. Phillips,1 N. R. Blatner,2 M. M. DeCamp,1,2 S. L. Meyerson,1,2 A. De Hoyos,1,2 H. C. Milad,1 J. R. Heiferman,1 D. J. Bentrem,1,2,3 K. Khazaie2; 1 Department of Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL; 2Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL; 3Jesse Brown VA Medical Center, Chicago, IL
7.18. Evaluation of TNFAIP3 Gene Polymorphisms as Prognostic Markers in Complete Resected Only Surgically Treated Esophageal Cancer. A. Stehr, M. Schmidt, A. Kutup, F. G. Uzunoglu, C. Gungor, J. R. Izbicki, Y. K. Vashist; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Hamburg
ASSOCIATION FOR ACADEMIC SURGERY AND SOCIETY OF UNIVERSITY SURGEONS—ABSTRACTS
7.2. The Prognostic Significance of Lymph Node Ratio in Melanoma. M. E. Egger,1 C. R. Scoggins,1 R. C. Martin,1 A. J. Stromberg,2 A. R. Quillo,1 K. M. McMasters,1 G. G. Callender1; 1 University of Louisville, Louisville, KY; 2University of Kentucky, Lexington, KY 7.3. Merkel Cell Carcinoma: High Recurrence Rate Despite Aggressive Treatment. M. C. Soult,1 E. C. Feliberti,1 M. L. Silverberg,2 R. R. Perry1; 1Eastern Virginia Medical School Department of Surgery, Norfolk, VA; 2Sentara Norfolk Gernal Hospital Department of Pathology, Norfolk, VA 7.4. Expression Profiles of Metalloproteinases in Cutaneous Squamous Cell Carcinoma. A. P. Tufaro,1 N. Prasad,1 A. Chuang,3 J. Wright,4 N. Liegeois,5 A. C. Fischer6; 1Johns Hopkins University School of Medicine, Baltimore, MD; 2Johns Hopkins University School of Medicine, Baltimore, MD; 3 University of Chicago Pritzker School of Medicine, Chicago, IL; 4Johns Hopkins University School of Medicine, Baltimore, MD; 5University of Maryland Medical Center, Baltimore, Maryland; 6UT Southwestern Medical Center, Dallas, TX 7.5. Oral Cavity Squamous Carcinoma; Effects of Primary Site on Survival. M. S. Wachtel, T. Nguyen, J. Cordero; Texas Tech University Health Sciences Center, Lubbock, TX 7.6. Molecular Mechanism of SFRP2 in Angiosarcoma and Development of SFRP2 Targeted Therapeutic. E. M. Fontenot,1 X. J. Shen,1 P. Ma,2 R. J. Mumper,2 S. SiamakpourReihani,1 B. Bone,1 E. G. Hilliard,1 D. P. Ketelsen,1 C. M. Ross,1 C. Patterson,1 N. Klauber-Demore1; 1UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; 2Department of Pharmacology, Chapel Hill, NC
University of Iowa Carver College of Medicine, Department of Surgery, Iowa City, IA 7.12. One-step Nucleic Acid Amplification (OSNA) Assay for Lymph Node Metastases in Lung Cancer Patients. M. Hayama,1 M. Chida,1 M. Nishihira,1 Y. Karube,1 M. Tamura,1 S. Kobayashi,1 T. Oyaizu,1 K. Honma2; 1Department of General Thoracic Surgery, Dokkyo Medical University, Shimotsuga, Tochigi; 2Department of Pathology, Dokkyo Medical University, Shimotsuga, Tochigi
7.13. Radioguided Detection of Lymph Node Metastasis in Non-Small Cell Lung Cancer. C. E. Nwogu,1,2 M. E. Reid,1 E. U. Dexter,1,2 P. N. Bogner,1 S. S. Yendamuri,1,2 C. D. Morrison,1 R. T. Cheney,1 D. Lamonica,1 A. Hutson,1,2 T. L. Demmy,1,2 A. A. Adjei1; 1Roswell Park Cancer Institute, Buffalo, NY; 2State University of New York at Buffalo, Buffalo, NY
7.14. Pre-Operative Core Muscle Cross-Sectional Area is Associated With Long-Term Survival Following Tri-Modality Management of Esophageal Carcinoma. K. H. Sheetz,1 L. Zhao,1 S. A. Holcombe,1 J. A. Hayman,3 S. G. Urba,2 R. M. Reddy,1 J. Lin,1 M. B. Orringer,1 S. C. Wang,1 A. C. Chang1; 1 University of Michigan Medical School, Department of Surgery, Ann Arbor, MI; 2University of Michigan Medical School, Division of Hematology/Oncology, Ann Arbor, MI; 3 University of Michigan Medical School, Department of Radiation Oncology, Ann Arbor, MI
7.15. Withdrawn 7.7. Fertility Preservation in Young Cancer Patients: Transplantation of Isolated Ovarian Follicles in Biomaterials in a Mouse Model of Infertility. A. N. Hardy,1 S. A. Boukaidi,5 L. D. Shea,2,3,4 J. S. Jeruss1,2; 1Department of Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL; 2The Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; 3Department of Chemical and Biological Engineering, Northwestern University, Evanston, IL; 4Institute for BioNanotechnology in Advanced Medicine, Northwestern University, Chicago, IL; 5Department of Gynecology and Obstetrics, University of Nice Sophia Antipolis, Nice, Provence Alpes Cote D’Azur 7.8. Imatinib-Resistant GIST Metastases: Predicting Outcomes of Surgical Resection. K. T. Chen, J. Farma, M. Von Mehren, J. C. Watson; Fox Chase Cancer Center, Philadelphia, PA 7.9. Does Complete Pathologic Response to Neoadjuvant Radiotherapy Predict Oncologic Outcome in Patients With Soft Tissue Sarcoma? D. R. Shah, D. Borys, S. R. Martinez, C. Li, R. J. Tamurian, R. J. Bold, R. J. Canter; University of California - Davis, Sacramento, CA 7.10. Importance of Connective Tissue Growth Factor in Sox2-Induced Oncogenesis. J. M. Hanna, M. Onaitis; Duke University Medical Center, Durham, NC 7.11. Mutations in SMAD4 Lead to Increased Invasive Potential. J. C. Carr, F. S. Dahdaleh, D. Wang, J. R. Howe;
7.16. Validation of Quantitative Histopathology in Identifying Aggressive Cutaneous Squamous Cell Carcinoma. E. S. Glazer,1 P. H. Bartels,1,3 A. R. Prasad,1,2,3 M. L. Yozwiak,3 H. G. Bartels,3 J. G. Einspahr,3 D. S. Alberts,1,3 R. S. Krouse1,2,3; 1The University of Arizona, Tucson, AZ; 2 Southern Arizona VA Health Care System, Tucson, AZ; 3The Arizona Cancer Center, Tucson, AZ
7.17. Regulatory T-cell Subpopulations in Patients With Pulmonary Adenocarcinoma. J. D. Phillips,1 N. R. Blatner,2 M. M. DeCamp,1,2 S. L. Meyerson,1,2 A. De Hoyos,1,2 H. C. Milad,1 J. R. Heiferman,1 D. J. Bentrem,1,2,3 K. Khazaie2; 1 Department of Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL; 2Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL; 3Jesse Brown VA Medical Center, Chicago, IL
7.18. Evaluation of TNFAIP3 Gene Polymorphisms as Prognostic Markers in Complete Resected Only Surgically Treated Esophageal Cancer. A. Stehr, M. Schmidt, A. Kutup, F. G. Uzunoglu, C. Gungor, J. R. Izbicki, Y. K. Vashist; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Hamburg